The gel slowly releases short gene sequences known as microRNAs into the heart muscle, according to researchers at the University of Pennsylvania in the US.
After a heart attack, there is a dramatic loss of these heart muscle cells and those that survive cannot effectively replicate.
With fewer of these contractile cells, known as cardiomyocytes, the heart pumps less blood with each beat, leading to the increased mortality associated with heart disease.
For the study, published in the journal Nature Biomedical Engineering, the researchers used mouse models to demonstrate a new approach to restart replication in existing cardiomyocytes.
They were able to inhibit some of the inherent "stop" signals that keep cardiomyocytes from replicating. This resulted in cardiomyocytes reactivating their proliferative potential.
With more heart cells dividing and reproducing, mice treated with this gel after heart attack showed improved recovery in key clinically relevant categories.
"Biologic drugs turn over very fast. The microRNAs that we used last less than eight hours in the bloodstream, so having a high local concentration has strong advantages," said Edward Morrisey, from the University of Pennsylvania.
Since these microRNAs are designed to promote cell proliferation, there would be a risk of tumour-producing, off-target effects.
"The most important traits of this gel are that it is shear-thinning and self-healing. Shear-thinning means it has bonds that can be broken under mechanical stress, making it more fluid and allowing it to flow through a syringe or catheter," said Jason Burdick, from the University of Pennsylvania.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
